Smartphone-supported single-session psychotherapy for postpartum depression
Official title: Motherly Plus: Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression
Run by University of Sao Paulo · NCT07925762 · Data updated 2026-11-12
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 104 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | September 9, 2026 |
| Main results expected | June 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07925762 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women 18–40 years old, up to 12 months postpartum, with MDD and sufficient smartphone access, who can read Brazilian Portuguese.
✕Probably not a fit
Individuals who do not show improvement or who do not engage with the app or online session may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial in Brazil compares a smartphone-assisted single-session psychotherapy focused on behavioral activation to a waitlist control. Participants receive one 90-minute online session and four weeks of guided app use via the Motherly app to apply strategies and access psychoeducation, with assessments at weeks 1, 2, 4 and 8. The study seeks to identify moderators of benefit and changes in behavioral activation as possible mediators of improvement. Eligible participants are 18–40 years old, up to 12 months postpartum, with DSM-5-TR major depressive disorder and a QIDS-SR16 score ≥13, and must own an Android smartphone. All outcomes are assessed remotely with masked evaluation.
Why it matters
Potential benefit: If successful, mothers may experience greater reduction in depressive symptoms and better access to scalable, digital mental health support.
How similar studies have gone: Evidence for single-session psychotherapy in postpartum depression is limited, with only a few prior trials using multi-hour group formats; this study tests a novel individual-session plus digital support approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 to 40 years * Up to 12 months postpartum * Score of 13 or higher on the Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR16) * Meets DSM-5-TR criteria for major depressive disorder, confirmed with the Mini-International Neuropsychiatric Interview (MINI) * Able to read and write in Brazilian Portuguese * Owns a personal Android smartphone with internet access Exclusion Criteria: * Intellectual, visual or hearing impairments, or chronic diseases that preclude smartphone use or comprehension of the intervention * Current or lifetime diagnosis of severe and/or chronic mental disorders (e.g., schizophrenia, bipolar disorder) * Current suicidal ideation with intent or plan, or suicide attempt in the previous week * Gestational loss (miscarriage) or early neonatal death in the index pregnancy * Treatment-resistant depression (nonresponse to at least 2 adequate previous evidence-based treatments) * Pharmacological treatment or psychotherapy in the previous 4 weeks
Where it's running
-
Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Daniel Fatori, PhD — University of Sao Paulo
- Study coordinator: Daniel Fatori, PhD
- Email: daniel.fatori@usp.br
- Phone: +55 11 2661-792
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MOVIN: a virtual program to support mental health during pregnancy and the early months after birth.
This project will test a virtual collaborative-care program called MOVIN to see if it reduces depression and anxiety in pregnant and postpartum people with infants up to 6 months old who have elevated symptoms.
-
Using external trigeminal nerve stimulation to treat migraines in pregnant women
This study is trying to see if a device that stimulates a nerve in the face can safely help pregnant women with migraines feel better.
-
Improving postpartum-to-primary care transitions for people with chronic conditions
This study tests whether embedding default PCP appointments, tailored reminder messages, and care recommendations into routine inpatient postpartum care helps people with chronic conditions connect with primary care after delivery.
-
Exploring how doulas help people with perinatal mood and anxiety disorders
This study is testing whether having a specially trained doula can help people dealing with mood and anxiety issues during and after pregnancy feel better.
-
Comparing high-intensity and moderate-intensity exercise during pregnancy and its effects on health and birth outcomes
This study tests whether high-intensity or moderate-intensity exercise during pregnancy can improve health and birth outcomes for moms and their babies.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.